SJS Investment Consulting’s Biogen BIIB Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-46
| Closed | -$8.92K | – | 1618 |
|
2024
Q3 | $8.92K | Buy |
46
+37
| +411% | +$7.17K | ﹤0.01% | 391 |
|
2024
Q2 | $2.09K | Sell |
9
-7
| -44% | -$1.62K | ﹤0.01% | 701 |
|
2024
Q1 | $3.45K | Sell |
16
-1
| -6% | -$216 | ﹤0.01% | 554 |
|
2023
Q4 | $4.4K | Sell |
17
-5
| -23% | -$1.29K | ﹤0.01% | 411 |
|
2023
Q3 | $5.66K | Buy |
22
+3
| +16% | +$771 | ﹤0.01% | 355 |
|
2023
Q2 | $5.41K | Buy |
19
+2
| +12% | +$570 | ﹤0.01% | 344 |
|
2023
Q1 | $4.73K | Sell |
17
-6
| -26% | -$1.67K | ﹤0.01% | 371 |
|
2022
Q4 | $6.37K | Buy |
23
+11
| +92% | +$3.05K | ﹤0.01% | 328 |
|
2022
Q3 | $4K | Buy |
+12
| New | +$4K | ﹤0.01% | 344 |
|
2022
Q1 | $5K | Buy |
23
+3
| +15% | +$652 | ﹤0.01% | 440 |
|
2021
Q4 | $5K | Buy |
+20
| New | +$5K | ﹤0.01% | 424 |
|